Barely Significant
← all phrases

“nominally significant”

7,733 sentences · 7,733 papers · 10,034 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

Nonetheless, a Bonferroni-corrected significant result was seen across all gene subsets for shorter stature, reduced chance of having a degree, and increased TDI; lower fluid intelligence, lower income, higher BMI, and an increased chance of being diagnosed with a child DD also remained nominally significant even in the 25 gene subset.
8 The exploratory nature and the lack of statistical evidence (ie, nominally significant p values) of a treatment by history of ASCVD interaction limits our conclusions on this subgroup analysis.
Only in the GAIN study did the authors report that controls with depressive symptoms were excluded from their analyses and they reported a nominally significant association between rs4333 and major depression in the same direction as ours 17 but in the reverse direction to that of Baghai et al. 12 Our data highlights the importance of controlling for lifetime major depression in the whole sample, as well as taking into account the potential for current depressive symptomatology in the control group.
When EA and BE cases were combined into a single case group and compared to the same set of controls, all three of these variants were highly-ranked among the set of 31 nominally significant SNPs ( S7 Table ), and two of the three (rs7526812 T>C, rs12534337 G>A) had smaller P values than observed in the individual analyses, without reaching Bonferroni or FDR significance thresholds. rs1644730 T>A is located within a predicted miR-630 binding site in the 3’UTR of all-trans-retinol dehydrogenase 8 ( RDH8 ), which encodes a short-chain dehydrogenase/reductase enzyme involved in rhodopsin regeneration in the vision pathway.
The nominally significant difference between early- and delayed-treatment groups was maintained at each time point, demonstrating that the effect of tolvaptan on slowing renal function decline in TEMPO 3:4 was maintained for an additional 2 years in TEMPO 4:4 (3.15 mL/min/1.73 m 2 , P < 0.001), (Figure 3 ).
Increases in HDL-C were observed for all subgroups except two (subjects receiving atorvastatin 10 mg and 20 mg with systolic blood pressure <130 mm Hg [diastolic <85 mm Hg], n = 11 and 21, respectively) and most changes were nominally significant.
Secondary outcomes with P < 0.0083 were considered statistically significant; those with 0.0083 ≤ P < 0.05 are reported as nominally significant but not conclusive and should be interpreted as exploratory. 2.7.3 Aggregation for satisfaction Satisfaction scores were aggregated per individual rater before between-group comparison, using the mean score across all cases for each rater.